In vitro studies demonstrate that the increased alloreactive T cell response to dendritic cells (DC) that are treated with either live or inactivated influenza virus A/PR/8/34 is due to viral neuraminidase (NA) activity. Since virus-specific cytotoxic T lymphocytes (CTL) play an important role in immunity to heterologous influenza strains, we compared the activation of CD8 ϩ T cells by untreated and NA-treated DC. Increased CTL activity was induced by NA-treated DC both in vitro and in vivo.
INTRODUCTION
The generation of cytotoxic T lymphocytes (CTL) plays a significant role in recovery from infection by influenza virus (Doherty et al., 1992) . The initiation of this response depends on the CD8 ϩ T cell's interaction with MHC class I peptide complex, costimulatory molecules, and adhesins on an activated dendritic cell (DC) (Banchereau et al., 2000; Schuurhuis et al., 2000) . CD4 ϩ T helper cells are usually required to activate DC (Ridge et al., 1998; Bennett et al., 1998; Schoenberger et al., 1998) . However, infection of DC with influenza virus results in an activated phenotype (Cella et al., 1999; Larsson et al., 2000) . This may explain why the generation of influenza virus-specific CTL does not require CD4 ϩ T cell help. This CD4 ϩ T cell independence has been demonstrated in vivo: mice that lack either CD4 ϩ T cells (Allan et al., 1990) or MHC class II (Tripp et al., 1995) generate a substantial number of CTL during the primary acute response to influenza virus.
Our in vitro studies demonstrate that the increased alloreactive T cell proliferation (Oh and Eichelberger, 1999; and IL-2 and IFN-␥ secretion in response to DC that are treated with either live or inactivated influenza virus A/PR/8/34 (PR8) are due to the viral neuraminidase (NA) activity. The effector cells used in these assays were bulk populations of T cells. Since the predominant subset in such a population is CD4 ϩ , it was important to establish that NA treatment of DC also enhanced CTL responses. We therefore examined the effect of desialylation on the generation of antigen-specific CD8 ϩ T cells and asked whether NA accounted for the CD4 ϩ T cell independence of the influenza virus-specific CD8 ϩ T cell response.
RESULTS

Treatment of DC with viral NA results in enhanced proliferation and cytotoxicity of alloreactive CD8 ϩ T cell responses in vitro
We isolated CD4 ϩ and CD8 ϩ T cells from the spleens of BALB/c mice and mixed them with DC that had been cultured from the bone marrow of C57BL/6 mice. As shown in Fig. 1 , proliferation of both allogeneic CD4 ϩ and CD8 ϩ T cells was increased by stimulation with DC that had been infected with PR8 or treated with NA. In contrast, infection with NWS-Mvi, a NA-deficient virus, or infection with PR8 in the presence of zanamivir, a NAspecific inhibitor, did not result in an increase in proliferation. Correlating with proliferation, increased amounts of IL-2 and IFN-␥ were detected in the super-natants of both allogeneic CD4 ϩ and CD8 ϩ T cell cultures that had been stimulated by NA-treated DC (results not shown).
To determine whether desialylation of DC altered the accessibility of molecules known to contribute to T cell activation, untreated, NA-treated, and PR8-infected DC, as well as DC that were infected with PR8 in the presence of zanamivir, were stained with antibodies to ICAM-1, B7-1, B7-2, and CD40. Immunostaining with anti-CD43, which is dependent on sialic acid for binding, demonstrated that the DC were indeed hyposialylated after NA treatment and PR8 infection and that infection in the presence of zanamivir inhibits NA activity (Fig. 2) . Increased CD103, CD11a, and CD62L immunofluorescence was observed after PR8 infection. For example, the mean fluorescence intensity (mfi) for CD103 before infection was 5.2 and after infection 10.4. This reflects a shift in the population of cells that is easily observed by an increase in the percentage of positively stained cells. Increased immunofluorescence with antibodies to CD103, CD62L, and CD11a was not NA-dependent: the increase was not observed when cells were treated with NA and was still observed when cells were infected in the presence of NA inhibitor (Fig. 2) .
The increased immunofluorescence with antibodies to CD40, ICAM-1, B7-1, B7-2, and MHC class II was, however, NA-dependent. Increased immunofluorescence was observed when DC were infected with PR8 in the absence, but not the presence, of a NA inhibitor. Similar increases were observed for DC treated with purified NA (Fig. 2) . These changes, although small (for example, the mfi for CD40 for untreated CD was 6.9 and on PR8infected DC was 8.2), were consistently observed in repeat experiments. The percentage change in mean fluorescence intensity for each cell surface marker after infection with NWS-Mvi was similar to the change after infection with PR8 in the presence of zanamivir (data not shown), further demonstrating the dependence on viral NA for these changes.
Since each of these molecules contributes to the activation of T cells, proliferation assays were performed in the presence of blocking antibodies to determine whether any of the molecules with increased accessibility contributes to the enhanced proliferation of CD8 ϩ and CD4 ϩ T cells. The proliferation of each subset of T cells in response to NA-treated DC was reduced in the presence of antibodies specific for ICAM-1, CD2, B7-1, and B7-2, but not CD62L (Fig. 3 ). The amount of inhibition was FIG. 2. Immunofluorescence of DC after treatment with viral NA or infection with PR8 in the absence or presence of zanamivir, compared with immunofluorescence of untreated DC. DC were cultured in the presence of GM-CSF for 7 days, washed, and then treated with purified viral NA (5 mU/ml) for 2 h at 37°C, infected with 2.5 m.o.i. PR8 for 4 h at 37°C in the presence or absence 1 mM zanamivir, of left untreated. Cells were incubated with FITC-conjugated antibodies with specificity for each of the cell surface molecules indicated or isotype controls (not shown). The average percentage differences in mean fluorescence intensity (mfi) obtained in at least three separate experiments are shown [i.e., 100 ϫ (mfi of treated DC Ϫ mfi of untreated DC)/mfi of untreated DC]. The SD was less than 20% of the difference in mfi. Immunofluorescence of infected cells with anti-CD103, CD11a, and CD62L was significantly different (determined by t test) from immunofluorescence with anti-CD40, B7-1, B7-2, ICAM-1, IA b , and K b . Staining with anti-CD43, CD40, B7-1, B7-2, ICAM-1, and IA b was significantly less on cells that had been treated with zanamivir.
FIG. 1. Proliferation of allogeneic (A) CD4 ϩ and (B) CD8 ϩ T cells to untreated, PR8-infected, Mvi-infected, and NA-treated DC. DC were prepared by in vitro culture of bone marrow cells from C57BL/6 (H-2 b ) mice and were either left untreated or infected with 2.5 m.o.i. of PR8 or Mvi, a NA-deficient virus. Zanamivir (1 mM), a viral NA inhibitor, was added to some DC during the PR8 infection. Some DC were treated with 5 mU/ml viral NA for 2 h at 37°C. After infection or NA treatment, DC were irradiated and washed and 5 ϫ 10 3 DC were mixed with 5 ϫ 10 5 T cells (H-2 d ) in quadruplicate wells of a round-bottom 96-well plate. Cultures were incubated at 37°C and 1 Ci [ 3 H]thymidine was added into each well on day 3. Incorporation was determined after a further 18 h incubation. The data shown represent the mean cpm Ϯ SE for four repeat experiments. Proliferation that is marked with an asterisk is statistically different (P Ͻ 0.05) from proliferation without PR8 infection, as determined by the Wilcoxon rank test. greatest in the presence of antibodies to ICAM-1, with almost 50 and 60% of the response of CD8 ϩ and CD4 ϩ T cells inhibited, respectively ( Fig. 3 ). Proliferation to untreated DC was not reduced to a similar extent.
To determine whether in vitro stimulation of T cells with NA-treated DC resulted in an increase in allospecific cytotoxicity, H-2 b DC that were untreated, or that had been infected with PR8 or treated with viral NA, were used to stimulate mixtures of CD4 ϩ and CD8 ϩ H-2 d T cells or CD8 ϩ T cells alone. Five days after stimulation, T cells were counted and added to 51 Cr-labeled MC57G cells at various effector:target (E:T) ratios. Both unseparated T cells and purified CD8 ϩ T cells that had been stimulated by NA-treated or influenza virus-infected DC had greater cytolytic activity than T cells stimulated by untreated DC (Table 1) .
Ex vivo treatment of DC with viral NA increases the in vivo peptide-specific CD8 ϩ T cell response
To determine whether desialylation of antigen-presenting cells can enhance the in vivo peptide-specific CD8 ϩ T cell response, BALB/c mice were immunized with peptide-loaded DC that were either NA treated or untreated. DC were loaded with either both MHC class I K d (HA 518-528 ) (Morgan et al., 1996) and class II (HA 111-119 )restricted (Kirberg et al., 1994) peptides from influenza hemagglutinin (HA) or only the MHC class I-restricted peptide. Following incubation with peptide, DC were divided into two groups: untreated and NA treated. Except for the addition of NA, each of these groups was handled in the same way, i.e., incubated for 2 h at 37°C, irradiated, washed, and counted. Three weeks after intravenous immunization of BALB/c mice with 5 ϫ 10 5 DC, splenocytes were restimulated with the same peptide(s) used for immunization, and the cytotoxicity of these cells was measured by lysis of 51 Cr-labeled HA 518-528 -pulsed P815 cells. Splenocytes from mice immunized with both MHC class I-and class II-restricted peptide-loaded DC had greater specific cytotoxicity than splenocytes from mice immunized with only MHC class I-restricted peptide-loaded DC ( Fig. 4 ), suggesting a contribution of CD4 ϩ T cells to the activation and expansion of antigenspecific CTL. This difference, however, was not observed in cultures from the mice immunized with NA-treated DC. In fact, in the absence of immunization with MHC class II-restricted peptide, CTL responses to NA-treated DC were greater than even those from mice immunized with untreated DC that had both peptides loaded.
To determine whether NA alters the cytolytic capacity of each cell, or whether our results reflect an increased a 5 ϫ 10 5 CD8 ϩ T cells or a mixture of CD4 ϩ and CD8 ϩ T cells from the spleens of H-2 d mice were stimulated with 5 ϫ 10 3 H-2 b DC that had been left untreated (none), treated with 5 mU/ml viral NA, or infected with 2.5 m.o.i. PR8. Cells were incubated at 37°C in round-bottom 96-well plates for 5 days before the 51 Cr release assay was performed.
b 51 Cr-labeled MC57G cells were used as targets at various E:T ratios. Data shown are for E:T of 10:1 and represent means Ϯ SD of triplicate cultures. Similar results were observed in three repeat experiments.
FIG. 3. Proliferation of (A) CD4 ϩ and (B) CD8 ϩ T cells to allogeneic NA-treated or untreated DC in the presence of antibodies to block specific cell surface molecules. In vitro-cultured DC (H-2 b ) were incubated for 2 h at 37°C with, or without, the addition of 5 mU/ml influenza virus NA. DC were then irradiated and washed, and 5 ϫ 10 3 DC were mixed with 5 ϫ 10 5 CD4 ϩ or CD8 ϩ T cells that had been purified from the spleens of H-2 d mice. Each antibody was added to quadruplicate cultures in round-bottom 96-well plates at 2 g/ml. On day 3, 1 Ci [ 3 H]thymidine was added to each well and incorporation determined after a further 18 h incubation. Each column shows the mean of quadruplicate cpm Ϯ SD. The percentage of the response to either untreated or NA-treated DC in the absence of any blocking antibodies is given beneath the relevant column. The data shown are the averages and SD for one of three experiments. In each experiment the reduction in proliferation to NA-treated DC was statistically significant in the presence of antibodies to B7-1, B7-2, ICAM-1, and CD2 (P Ͻ 0.01, t test), with the greatest decrease observed with anti-ICAM-1. number of activated antigen-specific CD8 ϩ T cells, the frequency of IFN-␥-producing cells in spleens of mice that were immunized with untreated and NA-treated DC was determined. Three weeks after immunization, spleens from five or six mice/group were restimulated in vitro with the peptide(s) that had been used to prime the response. The total number of splenocytes from mice immunized with NA-treated DC was slightly higher than that of splenocytes from mice immunized with untreated DC (for mice immunized with untreated vs NA-treated DC, the number of splenocytes without peptide immunization was 108 vs 114 ϫ 10 6 , with HA 518-528 only 117 vs 122 ϫ 10 6 , and with both HA 518-528 and HA 111-119 121 vs 124 ϫ 10 6 ). These differences were not statistically significant. The number of cells in each lymphocyte subset was calculated from the percentage of cells that stained positive for B220, CD4, and CD8. Splenocytes from mice immunized with both MHC class I-and II-restricted peptides had greater numbers of CD4 ϩ T cells than cultures from mice immunized with DC in the absence of antigen or with MHC class I-restricted peptide only. However, the difference between the number of CD4 ϩ T cells from mice that had been immunized with untreated DC and the number of CD4 ϩ T cells from mice that had been immunized with NA-treated DC was not significant. Mice immunized with both HA 518-528 and HA 111-119 had 32 vs 34 ϫ 10 6 CD4 ϩ T cells when DC were untreated or NA treated, respectively. In the absence of the MHC class II-restricted peptide, the number of CD4 ϩ T cells/spleen ranged between 26 and 29 ϫ 10 6 . However, there was a significant difference in the number of CD8 ϩ T cells induced by untreated and NA-treated DC (P Ͻ 0.05, Fig.  5A ). The difference was antigen-specific and was not as evident when immunization included MHC class II-restricted peptide since this resulted in a greater number of CD8 ϩ T cells in the culture, even when DC had not been treated with NA ( Fig. 5A) .
A significantly greater number of IFN-␥-producing CD8 ϩ T cells was present in the spleens of mice immunized with NA-treated HA 518-528 -loaded DC than with untreated HA 518-528 -loaded DC (P ϭ 0.05, Fig. 5B) . The difference was more clearly evident when the culture supernatants of spleen cells were analyzed for IFN-␥ production after restimulation. Lymphocytes from mice immunized with NA-treated DC pulsed with HA 518-528 only secreted significantly more IFN-␥ than lymphocytes from mice immunized with peptide-loaded DC that had not been treated with NA ( Fig. 5C ). Similar differences were observed when the numbers of peptide-specific CD8 ϩ T cells and IFN-␥ CD8 ϩ T cells that expand following immunization were calculated by subtracting the number of CD8 ϩ T cells present in mice that were immunized with DC that were not loaded with peptide. The mean numbers of antigen-specific CD8 ϩ T cells following immunization with HA 518-528 -loaded untreated and NA-treated DC were 4.0 ϫ 10 5 and 34.8 ϫ 10 5 , respectively. Following immunization with both HA 518-528 and HA 111-119 the numbers of peptide-specific CD8 ϩ T cells were 36.0 ϫ 10 5 and 49.8 ϫ 10 5 , respectively. The mean numbers of antigen-specific IFN-␥ ϩ CD8 ϩ T cells following immunization with HA 518-528 -loaded untreated and NA-treated DC were 0.12 ϫ 10 5 and 2.67 ϫ 10 5 , respectively, and with both HA 518-528 and HA 111-119 were 2.1 ϫ 10 5 and 3.67 ϫ 10 5 , respectively. Lymphocytes from mice immunized with NA-treated DC pulsed with both HA 518-528 and HA 111-119 secreted significantly more IFN-␥ than lymphocytes from mice immunized with peptide-loaded DC that had not been treated with NA (Fig. 5C ). The increased number of responding CD4 ϩ T cells probably contributes to this difference since these cultures were restimulated in the presence of both MHC class I and class II-restricted peptides. In contrast, the amount of IL-4 in culture supernatants was significantly less in cultures from mice immunized with NA-treated DC (Fig. 5D) .
CD8 ϩ T cell responses to influenza virus are retained in CD4-deficient mice that are infected with a NAdeficient virus
To address the contribution of NA to the generation of CD4 ϩ T-cell-independent responses in vivo, we examined the CD8 ϩ T cell response to NWS-Mvi, a NA-deficient virus, in the presence and absence of CD4 ϩ T cells. This virus was derived by selection of NWS/G70c (H1N9) FIG. 4 . The peptide-specific CD8 ϩ T cell response that is stimulated in vivo is enhanced by immunization with NA-treated DC. DC (H-2 d ) were incubated in 2 ml complete medium containing 10 g/ml MHC class I-or both class I-and class II-restricted peptides of influenza virus HA for 1 h at 37°C. After being washed, peptide-loaded DC were resuspended in complete medium, incubated in the presence or absence of viral NA as described for the previous figures, and irradiated. Groups of five or six BALB/c mice were immunized by intravenous injection of 5 ϫ 10 5 DC/mouse. After 3 weeks, splenocytes from individual mice were restimulated by culture for 5 days at 37°C in 10 g/ml of the immunizing peptides. The cytolytic activity of each culture to 51 Cr-labeled, class I peptide-loaded P815 was measured in triplicate wells at various E:T ratios. Results are shown at E:T of 30:1 and represent the mean % specific 51 Cr release for each of the mice in a group.
variants in the presence of exogenously provided bacterial NA (Liu and Air, 1993) . When mice were depleted of CD4 ϩ T cells by antibody (GK1.5) treatment, no differences in CD8 ϩ T cell responses were observed (results not shown). Since this lack of difference could have been the result of incomplete depletion, immunologically intact and CD4-deficient (CD4 (Ϫ/Ϫ)) C57BL/6 mice were infected intranasally with either the parental virus, NWS/ G70c, or NWS-Mvi. Ten days after infection, influenza virus-specific CD8 ϩ T cells were identified by staining with phycoerythrin (PE)-labeled H-2D b tetramers that were loaded with peptides from polymerase 2 (PA 224-233 ) and nucleoprotein (NP 366-374 ) (Belz et al., 2000) . Table 2 shows the number and percentage of CD8 ϩ T cells in the bronchoalveolar lavage (BAL) and draining mediastinal lymph nodes (MLN) that have specificity for D b -restricted PA 224-233 (D b PA 224 ) and for D b -restricted NP 366-374 (D b NP 366 ).
Although the number of D b PA 224 and D b NP 366 -specific CD8 ϩ T cell was less than the number of antigen-specific CD8 ϩ T cells in NWS/G70c-infected mice, Table 2 clearly shows that influenza virus-specific CD8 ϩ T cells are present in the BAL and MLN of both intact and CD4(Ϫ/Ϫ) mice after infection with NWS-Mvi. This shows that viral NA is not necessary to generate CD8 ϩ T cell responses in the absence of CD4 ϩ T cell help.
DISCUSSION
We have examined the induction of CD8 ϩ T cell responses by untreated and NA-treated DC in vitro and in vivo. When either CD4 ϩ or CD8 ϩ T cells were stimulated by allogeneic NA-treated DC in vitro, proliferation ( Fig. 1) and production of IL-2 and IFN-␥ (results not shown) were increased. Cytotoxicity of cultures containing allo- . BALB/c mice were immunized with 5 ϫ 10 5 DC/mouse. After 3 weeks, splenocytes were resuspended in complete medium containing 10 g/ml of the peptide(s) used for immunization and then cultured at 37°C for 24 h. Cells were immunostained and analyzed by flow cytometry to determine the number of IFN-␥-producing CD8 ϩ T cells. IFN-␥ and IL-4 were measured by ELISA in cell supernatants 2 and 3 days after restimulation of 1 ϫ 10 6 spleen cells with the immunizing peptides, respectively. The mean cell number or quantity of cytokine Ϯ SE (n ϭ 5 mice) is given. Statistically different (P Յ 0.05) results from mice immunized with NA-treated DC compared with untreated DC are marked with an asterisk, as determined by the Wilcoxon rank test. reactive CD8 ϩ T cells increased in a similar manner (Table 1) .
Our data do not show whether these increased responses reflect the activation of a larger number of precursor T cells or increased expansion of activated clones. The change in conformation of MHC class I and II molecules after desialylation may, for example, result in the activation of a larger number of allogeneic T cells. However, changes in the accessibility of key cell surface molecules may result in the activation of T cells with greater proliferative potential. Indeed, cells treated with NA had increased fluorescence when stained with antibodies to CD40, ICAM-1, B7-1, and B7-2. Each of these molecules contributed to the T cell response to NAtreated allogeneic DC. However, proliferation to NAtreated, but not untreated, DC was reduced the most in the presence of anti-ICAM-1 (Fig. 3) . A similar dependence on ICAM-1 has been demonstrated for T cell responses to NA-treated B cells (Bagriacik and Miller, 1999) . This is not surprising since ICAM-1 is a prominent cell surface antigen, extending approximately 40 nm from the plasma membrane, and is therefore one of the first antigens to facilitate stable contact between antigen-presenting cell and T cell (Dustin and Shaw, 1999) . Future studies will examine how sialic acid influences the interaction between ICAM-1 and its ligand, LFA-1.
The enzymatic activity of NA is essential for release of newly formed influenza virions form the infected host cell. Inhibition of NA with neutralizing antibodies or inhibitors therefore limits the spread of infection. Comparison of virus-specific CD8 ϩ T cell responses in the pres-ence or absence of such inhibition, or in response to intact versus NA-deficient viruses, is consequently likely to reflect differences in replication rather than the contribution of NA to T cell proliferation. To determine whether viral NA can enhance CD8 ϩ T cell responses in vivo, we therefore compared the responses to a MHC class I-restricted peptide, HA 518-528 , presented by DC that had, or had not, been treated with NA. Figure 4 shows that CD8 ϩ T cell cultures from the spleens of mice that were immunized with desialylated peptide-loaded DC have greater cytolytic activity than cultures from mice that were immunized with untreated DC. These results are the first to show that a CD8 ϩ T cell response can be enhanced by ex vivo treatment of DC with NA. Antigentransfected DC have been used in clinical trials to stimulate immune responses to tumors, and responses to such vaccines have been enhanced by cotransfection with costimulatory molecules or cytokines. Our results therefore provide an alternate method to enhance the immunogenicity of DC vaccines without presenting additional genes and/or cytokines to the recipient.
In our experiments, CTL responses to DC pulsed with MHC class I-restricted peptide only were poorly generated. This suggests that the CTL response to HA 518-528 is CD4 ϩ T cell dependent. However, the presence of some CD4 ϩ T cells generated in response to peptides generated from serum or other components during the ex vivo culture of DC may support the enhanced CTL response since they too will proliferate and secrete IL-2 in greater amounts when generated in response to NA-treated DC. Therefore, the enhanced CTL response after NA treat- a Groups of wild-type and CD4 (Ϫ/Ϫ) C57BL/6 mice were infected intranasally with 30 l NWS/G70c or NWS-Mvi. Ten days later, cells from the BAL of each group were pooled and MLN were individually harvested.
b Cells were stained with FITC-labeled anti-CD8 and PE-conjugated D b PA 224 and D b NP 366 tetramers as described under Materials and Methods. The percentage of CD8 ϩ T cells with antigen specificity is the percentage of CD8 ϩ T cells that stained positive with either D b PA 224 or D b NP 366 tetramers.
c The number of CD8 ϩ T cells with antigen specificity was calculated by multiplying the percentage of total cells that were tetramer ϩ with the total number of cells in BAL and MLN preparations. BAL was pooled from three to five mice and the number of cells is shown per mouse (i.e., the number of total lymphocytes was divided by the number of mice in the group). The average Ϯ SD percentage and number of antigen-specific CD8 ϩ T cells from the MLN are given for an experiment that included three to five mice per group. A separate experiment in which cells from pooled MLN and BAL samples from NWS/G70c and NWS-Mvi-infected wild-type and CD4 (Ϫ/Ϫ) C57BL/6 mice were stained with anti-CD8-FITC and D b PA 224 -PE or D b NP 366 -PE gave similar results. ment of DC (NA-treated DC loaded with HA 518-528 stimulated CD8 ϩ T cell responses to the same degree as untreated DC loaded with both HA 518-528 and HA 111-119 ) does not provide conclusive evidence that desialylation of DC can substitute for CD4 ϩ T cell help. To determine whether this is indeed possible, and is the reason for the CD4 ϩ T-cell-independent influenza virus-specific CTL response, we examined the CTL response generated to a NA-deficient influenza virus, NWS-Mvi, in mice that do not have CD4 ϩ T cells.
The majority of the influenza A virus-specific CD8 ϩ T cell responses in C57BL/6 mice are generated with specificity to D b PA 224 and D b NP 366 . The D b PA 224 -specific response is prominent in the primary immune response, but the D b NP 366 -specific CD8 ϩ NP-specific response is expanded in the secondary response (Belz et al., 2000) . Like responses to X-31 and PR8, D b PA 224 -specific CD8 ϩ T cells were more prominent than D b NP 366 -specific CD8 ϩ T cells in the BAL after NWS/G70c infection. In contrast, D b PA 224 -and D b NP 366 -specific CD8 ϩ T cells were induced with approximately equivalent frequency in mice infected with NWS-Mvi (Table 2) . This may result from differences in replication of these strains since in the absence of NA, infection by NWS-Mvi is limited (results not shown). It is interesting to note that while the specificity of almost 100% of the CD8 ϩ T cells in the BAL are accounted for in wild-type mice infected with NWS-Mvi, the D b PA 224 -and D b NP 366 -specific CD8 ϩ T cells comprise approximately 60% of the CD8 ϩ T cell population in CD4 (Ϫ/Ϫ) mice. This may reflect the presence of CD8 ϩ T cells that have limited expansion in the presence of CD4 ϩ T cells or activation of a greater repertoire of CD8 ϩ T cells due to the extended duration of viral replication in CD4-deficient mice (Allan et al., 1990) . From the latter explanation, one would expect the number of antigen-specific CD8 ϩ T cells in infected CD4 (Ϫ/Ϫ) mice to be greater than the number of CD8 ϩ T cells in wild-type mice. This was observed for mice infected with NWS/G70c but not with NWS-Mvi. Future studies will determine whether this was due to the limited replication of this NA-deficient virus or whether the absence of NA activity resulted in restricted expansion of these cells.
The BAL of both immunologically intact and CD4 (Ϫ/Ϫ) C57BL/6 mice had a substantial proportion of virus-specific CD8 ϩ T cells following infection with NWS-Mvi. Viral NA is therefore not responsible for the CD4 ϩindependent CTL response during influenza virus infection. A number of factors may contribute to the influenza virus-specific CD4 ϩ -independent CTL response. Characteristics of activated DC that are upregulated during influenza virus infection include increased expression of cell surface molecules B7-2 and CD40 (Cella et al., 1999) and cytokines IFN-␣ (Cella et al., 1999; Bender et al., 1998) , IL-1␤ (Pirhonen et al., 1999) , and IL-12 . Our results show that NA contributes to the apparent increase in expression of B7-2 and CD40 by increasing their accessibility. It has been suggested that some factors with increased expression in influenza virus-infected DC are induced by doublestranded (ds) RNA and it is assumed that this would occur via the activation of PKR (Cella et al., 1999) , a kinase that is activated by binding of dsRNA (Wu and Kaufman, 1996) . However, in the cell types studied to date, influenza virus uses at least two mechanisms to overcome the activation of PKR: the viral NS1 molecule itself binds to dsRNA and blocks the activation of PKR (Lu et al., 1995) and infection activates the expression of a 58-kDa protein that inhibits the activity of phosphorylated PKR (Melville et al., 1999; Tan and Katze, 1998) . The mechanism by which influenza virus activates DC may therefore be different from the activation of DC by dsRNA.
Identification of the mechanism that explains how influenza virus activates DC may lead to the design of novel adjuvants for vaccines that are aimed at inducing CTL responses or therapies that enhance immunity in individuals with low numbers of CD4 ϩ T cells. Although viral neuraminidase does not facilitate the CD4 ϩ -independent CTL response during influenza virus infection, NA treatment of dendritic cells does facilitate expansion of antigen-specific T cells. Desialylation may therefore be a useful strategy to enhance the immunogenicity of vaccines.
MATERIALS AND METHODS
Mice and cells
Five-to six-week-old female C57BL/6 (H-2 b ), BALB/c (H-2 d ), and CD4 (Ϫ/Ϫ) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed at Johns Hopkins University. They were used at 6 to 10 weeks of age as approved by the Animal Care and Use Committee, Johns Hopkins School of Public Health.
DC were prepared by culture of bone marrow from C57BL/6 or BALB/c mice as previously described . The cells were identified as DC by microscopic examination and immunostaining with antibodies to CD11c, B7-2, and MHC class II.
T cells from BALB/c spleens were prepared as previously described . CD8 ϩ T cells or CD4 ϩ T cells were separated by using rat anti-mouse CD8 (53-6.7) or rat anti-mouse CD4 (GK1.5) before incubation with magnetic beads (Dynal, Norway). The purity of T cells was greater than 95% as tested by flow cytometric analysis.
Infection and NA treatment of DC
Stocks of PR8, NWS/G70c, and NWS-Mvi were prepared and titrated on MDCK monolayers as previously described (Oh and Eichelberger, 1999; Liu and Air, 1993) . Briefly, allantoic fluid containing PR8 virus and tissue culture supernatant containing NWS/G70c or a NA-deficient NWS-Mvi virus were stored at Ϫ80°C. Virus titers were determined by infection of MDCK cells. Ten-fold dilutions of virus were made in serum-free DMEM (Life Technologies, Gaithersburg, MD) and 100 l of each virus dilution was added to quadruplicate wells containing a monolayer of MDCK cells in a 96-well plate. After 1 h incubation at 37°C, 100 l of DMEM supplemented with 3% BSA and 5 g/ml trypsin was added to the wells. For NWS-Mvi, the final culture medium also contained 1 mU/ml of Vibrio cholerae NA (Boehringer Mannheim). After 3 days incubation at 37°C, 25 l of the supernatant from each well was transferred into a round bottom 96-well plate. PBS (25 l) and 0.5% chicken red blood cells (50 l) were added and hemagglutination was observed after 30 min at room temperature. The inverse of the dilution at which 50% of the wells showed hemagglutination was recorded as the tissue culture infectious dose (TCID 50 ). The titer of each of the virus stocks was 10 9 TCID 50 /ml.
To infect DC, virus was added to tubes containing 1 ϫ 10 6 cells at m.o.i. of 2.5 in 2 ml PBS. After 1 h incubation at 37°C, 10 ml of RPMI containing 10% FCS and antibiotics (complete medium) was added, and the cells were incubated for 3 h at 37°C.
Purified viral NA (subtype N8) was kindly provided by Dr. Graeme Laver (John Curtin School of Medical Research, Canberra, Australia). Viral NA activity was determined by using fluorescent substrate as previously described (Oh and Eichelberger, 1999) . To treat cells with viral NA, 1 ϫ 10 6 DC were incubated for 2 h in complete medium containing 5 mU/ml NA at 37°C.
Both virus-infected and NA-treated DC were washed several times with complete medium, irradiated, and counted before they were added to T cell assays or used to immunize mice. Control DC were treated in the same way, except that virus or NA was not added. In some experiments, zanamivir (von Itzstein et al., 1993) , a virusspecific NA inhibitor, kindly provided by Glaxo-Wellcome, was included during PR8 infection or NA treatment at 1 mM.
Immunization with DC and infection with influenza virus
DC were incubated at 10 7 /ml for 1 h in PBS containing 10 g/ml peptide, washed, and then divided into two tubes, each containing cells at 10 6 /ml. Viral NA was added to one set of tubes for 2 h at 37°C. DC were washed, irradiated, and counted. BALB/c mice were immunized by intravenous injection of 5-6 ϫ 10 5 DC/ mouse. After 3 weeks, spleen cells from each mouse were restimulated with the same peptide(s) (10 g/ml) used for immunization. Mice were infected intranasally with 30 l NWS/G70c (1/40 dilution of stock) or NWS-Mvi (1/10 dilution of stock) while under sedation with Avertin (2,2,2-tribromoethanol).
Immunostaining of DC and T cells
PR8-infected and NA-treated DC were washed, incubated in 10% normal mouse serum for 30 min at 4°C, and stained with FITC-labeled rat anti-mouse CD103 (2E7), CD11a (2D7), CD62L (MEL-14), CD32/16 (2.4G2), CD43 (S7), CD43a (1B11), CD40 (HM40-3), ICAM-1 (3E2), B7-2 (GL1), B7-1 (16-10A1), IA b (25-9-3), and K b (AF6-88.5). All antibodies were purchased from Pharmingen (San Diego, CA).
To determine the number of T cells that contained intracellular cytokines IFN-␥ and IL-4, splenocytes from DC-immunized mice were incubated with immunizing peptide and Golgistop (Pharmingen) for 8 h. Cells were then stained with FITC-conjugated anti-CD4 or anti-CD8, fixed and permeabilized, and then incubated with cytokine-specific (or isotype control) biotinylated antibodies followed by PE-conjugated streptavidin. The reagents and detailed protocol were obtained from Pharmingen.
To identify antigen-specific CD8 ϩ T cells, lymphocytes from the BAL and MLN of virus-infected C57BL/6 mice were stained with either PE-conjugated D b PA 224 or D b NP 366 tetramers (Belz et al., 2000) at room temperature for 60 min in PBS containing 0.1% BSA and azide. The cells were washed once and then incubated with FITClabeled anti-CD8 for 30 min at 4°C. After they had been washed twice, immunofluorescence was analyzed by flow cytometry using either EPICS ELITE (Coulter) or FACScan (Becton-Dickinson, San Jose, CA) equipment and CELLQuest software.
Proliferation assays
To measure alloreactive T cell proliferation, DC (H-2 b ) were serially diluted in complete medium and 5 ϫ 10 2 -5 ϫ 10 4 cells were mixed with 5 ϫ 10 5 CD4 ϩ or CD8 ϩ (H-2 d ) T cells in quadruplicate wells of a 96-well roundbottom tissue culture plate (Costar, MA). After 3 days at 37°C, 1 Ci of [ 3 H]thymidine (Dupont, Boston, MA) was added into each well and the amount of 3 H incorporated measured as previously described (Oh and Eichelberger, 1999) . Specific antibodies were added in some experiments at 2 g/ml.
CTL assays
Five days after stimulation with allogeneic or peptideloaded syngeneic DC, T cells were counted and used as effector cells. The cytotoxic activity of allogeneic T cells was determined using 51 Cr-labeled MC57G (IA Ϫ D b K b ) target cells. The cytotoxic activity of peptide-specific T cells was measured in the same way using 51 Cr-labeled P815 (H-2 d ) target cells that had been incubated for 1 h with peptide HA 518-528 . A mixture of 5 ϫ 10 3 target cells and various numbers of effector T cells was incubated for 6 h at 37°C. The 51 Cr that was released into the supernatant was quantitated, and the percentage specific cytotoxicity was calculated using the formula 100 ϫ (cpm experimental Ϫ cpm spontaneous )/(cpm total Ϫ cpm spontaneous ).
Cytokine ELISA
Supernatants of cultures were harvested and used in cytokine-specific ELISA following protocols provided by Pharmingen. Cytokine-specific capture and detection antibody pairs, and recombinant cytokines, were purchased from Pharmingen. Immunolon I plates (Dynatech, Chantil, VA) were coated with capture antibodies for 24 h at 4°C before addition of culture supernatants. The manufacturer's protocol was followed for each subsequent step. OD 405 was measured on a kinetic microplate reader (Molecule Devices, Palo Alto, CA), and the amount of each cytokine was calculated from a standard curve generated from the titration of recombinant cytokine.
